Indivior Pharmaceuticals, Inc. (INDV) Capital expenditures 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$66.0MFY2025 · since FY2022: $5.0M → $66.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66.0M | +127.6% |
| FY2024 | $29.0M | +262.5% |
| FY2023 | $8.0M | +60.0% |
| FY2022 | $5.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice